Shares of Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as €58.00 ($63.74) and last traded at €57.40 ($63.08), with a volume of 201383 shares trading hands. The stock had previously closed at €58.05 ($63.79).
Carl Zeiss Meditec Price Performance
The stock has a market capitalization of $5.13 billion, a P/E ratio of 25.46, a price-to-earnings-growth ratio of 2.61 and a beta of 0.98. The business has a fifty day simple moving average of €62.95 and a 200 day simple moving average of €86.07. The company has a current ratio of 3.51, a quick ratio of 2.47 and a debt-to-equity ratio of 6.74.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- What Are Dividend Champions? How to Invest in the Champions
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- How to Most Effectively Use the MarketBeat Earnings Screener
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Investing In Automotive Stocks
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
